SOME ASPECTS OF LIPITENSION CORRECTION – A NEW PROBLEM IN MODERN CARDIOLOGY

Authors

  • L. V. Radetska Horbachevsky Ternopil State Medical University
  • N. I. Yarema Horbachevsky Ternopil State Medical University
  • I. V. Smachylo Horbachevsky Ternopil State Medical University
  • A. O. Bob Horbachevsky Ternopil State Medical University
  • Z. P. Mandzii Horbachevsky Ternopil State Medical University
  • A. I. Khomitska Horbachevsky Ternopil State Medical University
  • I. P. Savchenko Horbachevsky Ternopil State Medical University
  • L. V. Naumova Horbachevsky Ternopil State Medical University

DOI:

https://doi.org/10.11603/2415-8798.2018.3.9204

Keywords:

arterial hypertension, cholesterol, lipoproteins

Abstract

Lipitension is a modern term that describes the additive effect of arterial hypertension and hypercholesterolemia on the risk of cardiovascular disease (CVD). According to epidemiological studies, more than 50 % of patients with hypertension have hyperlipidemia.

The aim of the study – to evaluate the effectiveness of modern antihypertensive therapy in combination with statin therapy and ursodeoxycholic acid (UDCA) in patients with lipitension (arterial hypertension (hypertension) and hypercholesterolemia).

Materials and Methods. 36 patients with hypertonic disease (HD) of stage II, grade 2–3 and hypercholesterolemia were examined, which were performed a comprehensive clinical study, monitoring blood pressure (BP), and lipid metabolism on the basis of therapy by Difors, Atorvacor and Ursochol.

Results and Discussion. The results of monitoring blood pressure indicate the beneficial effect of this treatment on the daily blood pressure profile: after 2 months of treatment was recorded a significant reduction in average daily systolic and diastolic blood pressure. Under the influence of atorvastatin and ursochol, lipid metabolism rates improved, which was manifested by a significant decrease in the level of total cholesterol and low density lipoprotein cholesterol, a tendency to increase the content of high density lipoprotein.

Conclusions. In this article the combined use of antihypertensive therapy, statin therapy and ursochol in patients with lipentia, especially in clinical cases in which it is necessary to limit the dosage of statins in terms of improving the prognosis of patients with HD due to the synergism of antihypertensive and lipid-lowering potential and pleiotropic effects of these drugs, the effect which is aimed at slowing the progression of HD and atherosclerosis, was justified.

Author Biography

  • L. V. Radetska, Horbachevsky Ternopil State Medical University
     

References

Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., ... & Zannad, F. (2013). Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J. Hypertens, 31, 1925-1938.

Sirenko, Yu.М. (2010). Аrterialna hipertensia ta suputnia patoiohia [Arterial hypertension and concomitant pathology]. Donetsk : Isdatelskiy dom “Saslawskiy”, p. 383 [in Ukrainian].

Yusuf, S., Phil., J., Bosch, D. Zhu, J., Xavier, D., Liu, L., & Pais, P. (2010). Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. N. Engl. J. Med., 374, 2021-2031.

Pasetsko, N.W., Radetska, L.W., Yarema, N.І., Bob, A.O., Smachilo, I.V., Gavrilyuk, M.Ye., … & Osinchuk, G.I. (2018). Deiaki klinichni аspektu lipitensii [Some clinical aspects of lipentia]. Zdobutky кlinichnoi і experymentalnoi medycyny – Achievements of clinical and experimental medicine, 2, 246-249 [in Ukrainian].

Yusuf, S., Sleight, P., Anderson, C., Dyal, L., Copland, I., Schumacher, H., … & Anderson, C. (2008). Telmisartan, Ramipril, orboth for patients ofhigh risk of vascularevents. New Engl. J. Med., 358, 1547-1559.

Woronkow, L.G., Parasthenyuk, L.P., Lyashenko, А.W., & Тkatsh, N.А. (2013). Еfektswnist і perenosimist fiksowanoi kombinacii S(–) аmlodipin/аtorwastatin u pacientiw s аrterialnoyu hipertensieyu wisokogo sertshewo-sudinnogo risiku Efficiency and tolerability of the fixed combination S(-) amlodipine/atorvastatin in patients with hypertension of high cardiovascular risk]. Ukrainskyi меdychnyi chasopys – Ukrainian medical journal, 1, 73-75 [in Ukrainian].

Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Pojer, C., Zenz, R., … Stieger, B. (2001). Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology, 121, 170-183.

Downloads

Published

2018-10-09

Issue

No. 3 (2018)

Section

INTERNAL MEDICINE

License

Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. Результат пошуку зображень за запитом "CC-BY logo"         

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)

How to Cite

SOME ASPECTS OF LIPITENSION CORRECTION – A NEW PROBLEM IN MODERN CARDIOLOGY. (2018). Bulletin of Scientific Research, 3, 49-52. https://doi.org/10.11603/2415-8798.2018.3.9204